Seattle-based biomedical software firm Insilicos has named Jay Heinecke chief medical advisor of its scientific advisory board.
Heinecke is currently a molecular biology professor at the University of Washington Department of Medicine, director of the Mass Spectrometry Resource for the UW Department of Medicine, and Karasinski chair in Metabolic Research, where his work has focused on the role of oxidative reactions in the pathogenesis of atherosclerosis.